| Mr Raju N Vora, MD | |
|
80 Hospital Dr Ste 2, Barbourville, KY 40906-7363 | |
| (606) 545-4460 | |
| (606) 545-4469 |
| Full Name | Mr Raju N Vora |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 51 Years |
| Location | 80 Hospital Dr Ste 2, Barbourville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457367898 | NPI | - | NPPES |
| 000000062583 | Other | KY | BCBS |
| 64194590 | Medicaid | KY | |
| 1457367898 | Other | KY | INDIVIDUAL NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 19459 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Knox County Hospital | Barbourville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arh Mary Breckinridge Health Services, Inc. | 8123293818 | 53 |
| Arh Mary Breckinridge Health Services, Inc. | 8123293818 | 53 |
News Archive
In advance of the one-year anniversary of the Recovery and Reinvestment Act's enactment on February 17, twenty of the nation's leading research institutions, patient advocates and biomedical industry have released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.
EpiCept Corporation today provided an update on new clinical developments and other initiatives related to Ceplene® (histamine dihydrochloride), the Company's therapy approved in the European Union for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
Today's early morning highlights from the major news organizations include reports from a GOP presidential candidate forum in South Carolina and analysis of what to expect as Congress returns to Washington.
› Verified 3 days ago
| Entity Name | Vora & Vora, P.s.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760688634 PECOS PAC ID: 0244227478 Enrollment ID: O20071112000371 |
News Archive
In advance of the one-year anniversary of the Recovery and Reinvestment Act's enactment on February 17, twenty of the nation's leading research institutions, patient advocates and biomedical industry have released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.
EpiCept Corporation today provided an update on new clinical developments and other initiatives related to Ceplene® (histamine dihydrochloride), the Company's therapy approved in the European Union for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
Today's early morning highlights from the major news organizations include reports from a GOP presidential candidate forum in South Carolina and analysis of what to expect as Congress returns to Washington.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Raju N Vora, MD 80 Hospital Dr Ste 2, Barbourville, KY 40906-7363 Ph: (606) 545-4460 | Mr Raju N Vora, MD 80 Hospital Dr Ste 2, Barbourville, KY 40906-7363 Ph: (606) 545-4460 |
News Archive
In advance of the one-year anniversary of the Recovery and Reinvestment Act's enactment on February 17, twenty of the nation's leading research institutions, patient advocates and biomedical industry have released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.
EpiCept Corporation today provided an update on new clinical developments and other initiatives related to Ceplene® (histamine dihydrochloride), the Company's therapy approved in the European Union for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
Today's early morning highlights from the major news organizations include reports from a GOP presidential candidate forum in South Carolina and analysis of what to expect as Congress returns to Washington.
› Verified 3 days ago
Ashutosh S. Lohe, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 315 Hospital Drive, Suite 5, Barbourville, KY 40906 Phone: 506-545-6491 Fax: 606-545-0342 | |
Syed Kamran Hasni, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 315 Hospital Dr, Ste 5, Barbourville, KY 40906 Phone: 606-545-6491 Fax: 606-545-0342 |